However, despite these limitations, this study suggests that tumor microenvironmental factors must be considered in aggregate and that the control of tumor microenvironmental factors, and/or expression of CA IX and VEGF, should be among the important targets for examination in the development of future therapies for malignant tumors. This evidence concerns the gene VEGFA and neoplasm.